Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
02/2008
02/05/2008US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs
02/05/2008US7326702 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example
02/05/2008US7326701 Lactam compounds and pharmaceutical use thereof
02/05/2008US7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
02/05/2008CA2383315C New derivatives of pyrimidin-4-ones, the process for the preparation thereof and the pharmaceutical compounds that contain them
02/05/2008CA2315703C Tripeptidyl peptidase inhibitors
01/2008
01/31/2008WO2008013997A2 Fluorescent substrates for monoamine transporters as optical false neurotransmitters
01/31/2008WO2008013269A1 Isoquinuclidine derivative and method for producing 1-cyclohexene-1-carboxylic acid derivative by using the same
01/31/2008WO2008012623A1 Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
01/31/2008WO2008012361A2 Dimethano-[1,3] dioxocino [6,5-d] pyrimidine-spiro derivatives of tetrodotoxin, process for their synthesis and uses thereof in the treatment of pain
01/31/2008WO2008012003A1 Camptothecin derivatives with antitumor activity
01/31/2008WO2008011994A1 Camptothecin derivatives with antitumor activity
01/31/2008WO2008011992A1 Camptothecin derivatives with antitumor activity
01/31/2008WO2007140297A3 Aziridinyl-epothilone compounds
01/31/2008US20080027224 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin
01/31/2008US20080027091 Soft anticholinergic zwitterions
01/31/2008US20080027069 Quinazoline compounds
01/31/2008US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio)
01/31/2008US20080027049 Benzofurans as potassium ion channel modulators
01/31/2008CA2659050A1 Camptothecin derivatives with antitumor activity
01/31/2008CA2658902A1 Camptothecin derivatives with antitumor activity
01/31/2008CA2658900A1 Camptothecin derivatives with antitumor activity
01/30/2008EP1882692A1 Dimethano-[1,3]dioxocino[6,5-D]pyrimidine-spiro derivatives of tetrodotoxin, process for their synthesis and uses thereof in the treatment of pain
01/30/2008EP1882690A2 A process for the preparation of epothilone analogs and intermediates
01/30/2008EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists
01/30/2008EP1881827A1 Fused thiazole derivatives as kinase inhibitors
01/30/2008EP1521757B1 tricyclic spiropiperidines or spiropyrrolidines
01/30/2008CN101115719A Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
01/30/2008CN101115715A Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
01/30/2008CN101115486A Novel farnesyl protein transferase inhibitors and their use to treat cancer
01/30/2008CN101113151A Snail lactam compound and preparation method and usage thereof
01/30/2008CN100364995C Production of galantamine
01/29/2008US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of
01/29/2008US7323573 Production of polyketides
01/29/2008US7323569 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine.
01/29/2008US7323494 Liver X receptor(LXR) modulating agents, agonists; useful in increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, treating cardiovascular disease, inflammation; 2-[2-{[4-methoxy-benzyl](2,2-diphenylethyl)amino}ethyl]-5-benzofuran acetic acid
01/29/2008US7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
01/29/2008US7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
01/29/2008US7323473 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for treatment of obesity
01/29/2008CA2256336C Quinolinomorphinan derivative and medical use thereof
01/24/2008WO2008011611A2 Compounds and compositions as itpkb inhibitors
01/24/2008WO2008010765A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity
01/24/2008WO2008009700A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
01/24/2008WO2008009695A1 Rearrangement of spirolactams
01/24/2008WO2008009416A1 Spirocyclic azaindole derivatives
01/24/2008US20080021224 Supports such as glass and styrene polymers functionalized with tricyclic hetercyclic anhydrides and imides, used in the preparation of oligonucleotides
01/24/2008US20080021210 Compositions and methods of making a photoactive agent
01/24/2008US20080021050 Compounds, compositions, and methods
01/24/2008US20080021047 C-Purine Nucleoside Analogs As Inhibitors Of Rna-Dependent Rna Viral Polymerase
01/24/2008US20080021042 Composition For Controlling Neuropathic Pain
01/24/2008DE102006033114A1 Spirocyclische Azaindol-Derivate Spirocyclic azaindole derivatives
01/24/2008CA2658379A1 Spirocyclic azaindole derivatives
01/24/2008CA2658261A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
01/24/2008CA2657639A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity
01/24/2008CA2656715A1 Compounds and compositions as itpkb inhibitors
01/23/2008EP1880996A1 Spiroindolinepiperidine derivatives
01/23/2008EP1880995A1 Method for producing indole derivative having piperidine ring
01/23/2008EP1879847A1 Terrylene and quaterrylene derivatives
01/23/2008EP1322651B1 Bicyclic heteroaromatic compounds
01/23/2008EP1322619B1 Isoquinolinone potassium channel inhibitors
01/23/2008CN101108825A Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
01/23/2008CN100363366C Camptothecin derviative and preparation process thereof
01/23/2008CN100363348C PgD2 receptor antagonists for the treatment of inflammatory diseases
01/22/2008US7321040 MAP (mitogen-activated protein) kinase inhibitors; osteoarthritis, rheumatoid arthritis, anticarcinogenic or antiischemic agents; reperfusion injuries, strokes or heart attack; autoimmune, skin, cardiovascular, brain, bone, neurodegenerative, respiratory system and nervous system disorders
01/22/2008US7321039 Industrial process for preparing tropenol
01/22/2008US7321033 Having immunomodulatory activity; for therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus
01/22/2008US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents
01/22/2008US7320978 Inflammations of the respiratory system, locomotor system traumas, and edemas; 1-{[5-(4-Chlorophenyl)-4-(2,4-dichlorophenyl)-1,3-oxazol-2-yl]carbonyl}-4-(3-methylphenyl)piperazine
01/22/2008CA2300405C Use of cholinesterase inhibitors for treating attention deficit disorders
01/17/2008WO2008007132A1 Tetrahydrofuro [3, 2-b] pyrr0l-3-0ne intermediates
01/17/2008WO2008007130A1 Furo [3,2-b] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
01/17/2008WO2008007127A1 Furo [3,2-b] pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
01/17/2008WO2008007114A1 Tetrahydrofuro [3, 2 -b] pyrr0l-3-ones as cathepsin k inhibitors
01/17/2008WO2008007112A1 Tetrahydrofuro [3, 2-b] pyrr0l-3-ones as cathepsin k inhibitors
01/17/2008WO2008007109A1 Furo[3,2-b]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
01/17/2008WO2008007107A1 Tetrahydrofuro (3, 2-b) pyrrol-3-one derivatives as inhibitors of cysteine proteinases
01/17/2008WO2008007103A1 Furo [3, 2-b] pyrrol derivatives
01/17/2008WO2008006702A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds
01/17/2008US20080015365 reacting malonic acid with ketones such as methyl isobutyl ketone, 2-pentanone, cyclopentenone, cyclohexanone, adamantanone, cyclooctanone, ethyl levulinate, cyclohexane-1,4-dione, pinacolone or acetophenone, in solvents to form 1,3-dioxan-4,6-dione compounds, used as intermediates for drugs or pigments
01/17/2008US20080015276 7.9 diethyl-6,7,9-trimethyl-8-(1-phenyl-ethoxy)-1,4-dioxa-8-aza-spiro[4.5]decane initiator for polymerizing ethylenically unsaturated monomer(s); low polydispersity
01/17/2008US20080015183 Substituted quinazolin-4-ylamine analogues
01/17/2008US20080015179 such as ethyl 3-(1'-methyl-2'-oxospiro[cyclohexane-1,3'-indoline]-4-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate, used for the treatment of nervous system disorders, psychological disorders, autoimmune diseases, gastrointestinal disorders, vision defects, obesity and cardiovascular disorders
01/17/2008US20080015157 Novel Water-Soluble Prodrugs
01/17/2008US20080014614 Labeling of rapamycin using rapamycin-specific methylases
01/17/2008CA2658223A1 Benzopyranopyrazoles
01/17/2008CA2657816A1 Tetrahydrofuro [3, 2 -b] pyrr0l-3-ones as cathepsin k inhibitors
01/17/2008CA2657797A1 Tetrahydrofuro [3, 2-b] pyrrol-3-one intermediates
01/17/2008CA2657078A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds
01/17/2008CA2655202A1 Glucocorticoid receptor modulator and methods of use
01/16/2008EP1877410A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity
01/16/2008EP1877379A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
01/16/2008EP1451154B1 Inhibitors of cytosolic phospholipase a2
01/16/2008CN101107254A Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
01/16/2008CN101107252A Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases
01/16/2008CN101107231A Imidazole and benzimidazole derivatives useful as histamine H3 antagonists
01/15/2008US7319106 such as (cis)-6-(3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane; for controlling synaptic transmission, neurotransmitter release
01/15/2008US7319105 Cytotoxic agents
01/15/2008US7319103 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders
01/15/2008US7318823 Methods for repairing damaged intervertebral discs
01/10/2008WO2008005308A2 Compositions and methods of making a chlorin e6 derivative as a photoactive agent